Lifeforce Capital
Chevy Chase, Maryland · Invests in US · Website
Check size
$500K-$5M
Thesis
Healthcare's largest markets are ripe for disruption through software-first solutions. We back companies advancing care delivery through new technologies and care models, and software-first techbio platforms that transform drug discovery and therapeutic development.
Likely not a fit for
No consumer-only apps without healthcare impact; no pharma companies without software-first approach; no devices without software layer
How they invest
- Lead or follow
- Leads or follows
- Typical decision
- 3+ months
- Warm intro
- Preferred
- Involvement
- Takes a board seat
- Fund status
- Actively deploying
- Decision process
- Partnership vote
Partners & team
1 contact on file
John Noonan
Founder and General Partner · Primary contact
Portfolio
Able Health provides home health care services including skilled nursing, home health aides, and specialized care for individuals with developmental disabilities.
Advantia Health is dedicated to transforming healthcare for women, offering a range of services including gynecology, obstetrics, maternal fetal medicine, and mental wellness, with a focus on patient experience and accessibility through technology.
Aspire Health offers a range of holistic health services including naturopathic medicine, occupational therapy, acupuncture, and nutrition counseling, focusing on individualized care and wellness.
Bayesian Health is a clinical AI company focused on real-time clinical intelligence to improve patient care and outcomes, particularly in monitoring and managing conditions like sepsis.
Belle.ai offers AI-powered skin healthcare technology for professionals. It enhances client engagement and improves treatment outcomes.
Character Bio is a precision medicine company unlocking the patterns of progressive polygenic diseases, with an initial focus on macular degeneration.
Circle Pharma is dedicated to transforming cancer treatment through the power of macrocycles, aiming to create effective therapies that minimize side effects for patients.
Clover Health is a healthcare technology company focused on improving healthcare through technology and preventive care. It offers Medicare Advantage plans and employs a dedicated care management team.
Cricket Health is dedicated to reimagining kidney care by providing personalized support and innovative solutions for patients with chronic kidney disease (CKD). Their approach focuses on value-based care, improving health outcomes, and enhancing the patient experience through coordinated efforts among patients, providers, and payers.
Dr. Consulta offers accessible healthcare services including consultations, exams, and telemedicine, with a focus on quality and affordability for families.
Eko Health specializes in digital stethoscopes and AI-driven disease detection solutions, integrating telehealth capabilities for enhanced patient care.
Recent activity
- Mar 2026
Carecubes
Series A · Participant
- Nov 2025
Aspen Neuroscience
Series C · Participant
- Mar 2025
Character Biosciences
Series B · Participant
Lifeforce Capital in the news
The Business Journals
How a biotech startup, with fresh cash from key VCs, is using AI to spin macrocycles
Jun 2024
Biotech company Vilya lands cash for disease-fighting 'macrocycles'
Jun 2024
Biotech Startups Get Seed Funding From Tech Venture-Capital Investors
Mar 2022
Verge Genomics Secures $98 Million in New Financing
Dec 2021
Fauna Bio Raises $9 Million to Expand Comparative Genomics Platform for Novel Target Discovery
Sep 2021
The Funded: Abu Dhabi investor takes big stake in Menlo Park private equity firm
Sep 2020
Digital health startup based in Houston closes $5.8 million round
Jan 2020
Personalized cancer treatment startup Notable Labs nabs $40M Series B
Jul 2019
Mayo Backs Software Startup Looking to Accelerate Cancer Cure Process
Jun 2017
Similar firms
MBX Capital is a venture capital fund with a "deep health" thesis that treats health as a systems problem. They invest across biology, chemistry, AI/ML, robotics, and clinical medicine to back companies addressing root causes of environmental health and healthcare infrastructure challenges. The fund makes $1–2.5M first checks targeting ≥5% equity and operates with a private "Atom Network" of hundreds of scientific and clinical experts who help source and vet investments.
Solo-GP venture capital fund founded and managed entirely by Dr. Ling Wong, an MIT-trained chemical engineer and biologist with a Harvard PhD who invented the world's first inhaled tuberculosis vaccine. The fund writes checks from $500K to $50M across seed through growth stages, backing breakout companies like Slack (acquired by Salesforce for $27.7B), Guardant Health (IPO), and Anacor (acquired by Pfizer for $5.2B) while co-investing alongside top-tier firms like Andreessen Horowitz and Sequoia.
F-Prime Capital is one of the few large global VC firms that has built over 30 companies from scratch rather than just backing existing startups, drawing on Fidelity's resources to combine deep healthcare and technology expertise with a structured company-formation engine that pulls together academic founders across multiple geographies. The firm operates with sister fund Eight Roads to create one of the broadest cross-border VC footprints, systematically syndicating ideas across the U.S., Europe, China, Japan, India, and Israel while maintaining a distinctive "technical-risk-yes, regulatory-risk-no" filter that avoids heavy regulatory categories like broad antibiotics in favor of rare diseases and gene therapy where FDA pathways are clearer.
Healthcare-only platform spanning seed through IPO and beyond via public, private and credit/royalty arms; acts as a biotech IPO accelerator and validation, aiding NASDAQ/HKEX listings and confidential financings.
Research briefRead more
Add Lifeforce Capital to your investor list
Sign up free to save investors, see partner contacts, and track your raise.
Sign up